Pharmaceutical manufacturers face growing pressure to move beyond isolated automation islands. They need fully connected, plant-wide systems instead. Biophorum’s Digital Plant Maturity Model makes it clear: Level 3, the connected plant, is now table stakes to compete. yet many companies still struggle to make the leap. Data stays fragmented across systems. Operator interfaces vary wildly.…
AstraZeneca invests $300 million to establish new cell therapy manufacturing facility in Maryland
Maryland Governor Wes Moore announced that AstraZeneca would invest $300 million to construct a new manufacturing facility in Rockville, a city with roughly 70,000 inhabitants that is about 17 miles from Washington, D.C. The facility will focus on cell therapies for cancer treatment. The 84,000 square-foot facility, slated for completion in 2026, will enable global…